Myelin basic protein (MBP)-specific T cells play a critical role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a prototype for T cell-mediated autoimmunity. In PL/J and B10.PL mice (H-2 u haplotype), the immunodominant epitope of MBP is represented by an N-terminal nonameric peptide, MBP1-9. To date, the MBP1-9-specific T cell repertoire has not been analyzed in quantitative terms. In the present study we demonstrate, using MHC class II tetramers, that 15,000-70,000 self-antigen-specific T h cells accumulate in the draining lymph nodes following immunization with spinal cord homogenate or MBP1-9. In contrast, MBP1-9-specific T cells are undetectable in unimmunized H-2 u mice and represent >60% of the CD4 cells in naive mice transgenic for a TCR specific for this epitope. The results suggest that the extremely low affinity of the N-terminal peptide for I-A u does not limit the MBP1-9-specific T cells from expanding into a sizeable pool of autoreactive T cells. Therefore, the primary immune response to MBP1-9 does not differ quantitatively from previously reported CD4 ⍣ T cell responses to foreign antigens.
Introduction
Murine experimental autoimmune encephalomyelitis (EAE) is some of the commonly used models (3,5,7,14,15). By combining the use of acidic/basic zippers to stabilize αβ chain believed to be a representative model of T cell-mediated association together with the covalent tethering of antigenic autoimmune disease and, more specifically, of multiple peptide, we recently described the expression of a functional, sclerosis (reviewed in 1). In H-2 u mice, the immunodominant recombinant I-A u molecule complexed with the N-terminal epitope of MBP is represented by an N-terminal peptide, 11mer of MBP (16) . In the current study we have produced MBP1-9 (2), that binds to its restricting element, I-A u , with these recombinant molecules in multimeric form and assessed low affinity (3,4). This weak interaction has been suggested their ability to bind diverse encephalitogenic T cell populato result in the escape of autoreactive T cells from tolerance tions. We have also analyzed the frequency of MBP1-9-induction (3,5). Taken together with recent data indicating specific T cells in transgenic mice expressing a MBP-specific that MBP peptides with higher affinity for I-A u induce negative TCR and in MBP1-9-or spinal cord homogenate (SCH)-selection of cognate T cells (6,7), this might explain the immunized non-transgenic animals. Our results demonstrate encephalitogenic potential of this N-terminal peptide. Despite that a very low number of MBP1-9-specific T cells in naive the extensive use of this peptide to induce EAE, little is known mice (below the detection limit of our method) is efficiently about the frequency of MBP1-9-specific T cells in naive or expanded by autoantigen immunization, despite the low affinimmunized mice. In this respect, multimeric peptide:MHC ity of MBP1-9 for I-A u . complexes have recently proved to be valuable reagents for 'counting' and characterizing antigen-specific T cells, especially for class I-restricted responses (reviewed in 8). In Methods contrast, there appears to be a paucity of data involving the T cell hybridomas and transfectants application of such complexes for CD4 T cells (9-13). For mouse models of autoimmunity, this might be due to the The 1934.4 T cell hybridoma (17) is specific for the N-terminal 11mer (or nonamer) of MBP bound to I-A u . P1.D2 T cells were relative instability of peptide:I-A complexes associated with generated by transfecting the 1934.4 TCR genes into a TCR -/ between the honey bee melittin signal peptide and the β u chain sequence. The KpnI site was used to insert the codons CD4 -cell line (58α -β -) [as described elsewhere (18) ]. The DO11.10 T cell hybridoma (19) is specific for residues 323-corresponding to the antigenic peptide, rat MBP1-11 (ASQKRPSQRHG, note that the core epitope of MBP1-9 is 339 of ovalbumin presented by I-A d , and was a generous gift from Drs J. Kappler and P. Marrack (University of Colorado identical to the murine counterpart) or a derivative of this peptide in which the lysine at position four was replaced Health Sciences Center, Denver, CO). These cells were maintained in RPMI 1640 medium (Life Technologies, by tyrosine ('4Y'). A glycine was inserted before the MBP sequence, as this residue can substitute for the N-terminal Gaithersburg, MD) supplemented with 10% FCS (Life Technologies), penicillin/streptomycin (100 U/ml) and 2 mM acetyl group required for T cell recognition (D. C. Wraith, unpublished observation). The α and β chains were truncated L-glutamine.
before the transmembrane region and sequences encoding Mice, antigens, immunization protocols and generation of acidic and basic zippers were appended as described (16) .
T cell lines
In the β chain construct the basic zipper was followed by a The Tg4 transgenic mouse expressing the 1934.4 TCR has sequence encoding a biotinylation signal peptide similar to been described previously (20) . Tg4, B10.PL and that described previously (24) . Both α and β chain constructs B10.PLϫSJL/J (H-2 uϫs ) F 1 mice were bred under specific were tagged with sequences encoding C-terminal polypathogen-free conditions at the School of Medical Sciences histidine tags, and were cloned as a BglII or BamHI fragment (University of Bristol, UK). SCH was prepared as previously respectively in the dual baculovirus expression vector described (21) . MBP1-9 (AcASQKRPSQR) was synthesized pAcUW51 (PharMingen, San Diego, CA). The resulting on an Abimed AMS 422 multiple peptide synthesizer (Abimed, plasmid was co-transfected with Baculogold DNA Langenfeld, Germany). Mice were immunized s.c. in one hind (PharMingen) into Sf9 cells and high-titer recombinant virus leg with a total of 100 µl antigen emulsified with complete stocks were generated and used to infect HIGH FIVE TM cells Freund's adjuvant (CFA) supplemented with 4 mg/ml (Invitrogen, Carlsbad, CA). The 72 h supernatants were Mycobacterium tuberculosis strain H37RA (Difco, Detroit, MI).
subjected to chromatography on a Y3P (25)-Protein M. tuberculosis purified protein derivative (PPD) was obtained A-Sepharose (Pharmacia, Piscataway, NJ) affinity column. from the UK Central Veterinary Laboratory (Weybridge, UK).
Recombinant proteins were eluted with 100 mM Na 2 CO 3 / Each mouse received either 1 mg SCH as a source of myelin 150 mM NaCl, pH 11.2 and immediately neutralized using or 200 µg of MBP1-9 peptide. Ten days later, draining lymph 2 M Tris-HCl, pH 7.4. Following a second step of affinity nodes (inguinal and popliteal) were removed and used as a purification on Ni-NTA 2ϩ -agarose (Qiagen, Valencia, CA), source of primed lymph node cells (PLNC) for flow cytometric proteins were dialyzed into 10 mM Tris-HCl, 50 mM NaCl, analysis and generation of T cell lines. Generation of the pH 7.4. Biotin ligase (Avidity, Denver, CO) and biotin were Tg4.TCL and 4Kuxs.TCL cell lines has been described previadded to a final concentration of 10 µg/ml and 40 µM ously (22) . Briefly, the Tg4.TCL was generated using splenorespectively, and after 24 h at room temperature the reaction cytes from an unimmunized Tg4 transgenic mouse by primary mixture was extensively dialyzed into PBS to remove the free in vitro stimulation with MBP1-9 peptide. The polyclonal biotin. Tetrameric peptide:I-A u complexes were prepared by 4Kuxs.TCL was derived from H-2 uϫs mice immunized with adding phycoerythrin (PE)-labeled streptavidin (Biosource MBP as described above and then generated by in vitro International, Camarillo, CA) or Extravidin (Sigma, St Louis, stimulation of PLNC with MBP1-9. The 170.1 T cell clone is MO) to the purified proteins at a molar ratio of 1:4. specific for MBP89-101 presented by I-A s (S. M. Anderton, Tetramer staining manuscript in preparation). For generation of short-term cell lines, PLNC from SCH or MBP1-9 immunized mice were Cells were incubated with tetramers for 3 h at 20°C or for maintained in X-VIVO 15 TM serum-free medium (BioWhittaker, 30 min at 37°C. An antibody specific for the CD3ε chain (145-Walkersville, MD) supplemented with 2 mM L-glutamine (Life 2C11; PharMingen) was added (at 10 µg/ml) together with Technologies) and 5ϫ10 -5 M 2-mercaptoethanol. Cells were the tetramers since preliminary experiments showed that this re-stimulated with either 20 µM MBP1-9 or 5 µg/ml PPD. improved tetramer staining. A similar observation was recently Three days later, viable cells were isolated using a Nycoprep reported by Kotzin et al. (13). Cells were analyzed by flow 1.077 animal density gradient (Nycomed Pharma, Oslo, cytometry (FACScan; Becton Dickinson, Mountain View, CA). Norway) and expanded in IMDM (Life Technologies) supple-
In some experiments cells were co-stained with an antibody mented with 2 mM L-glutamine (Life Technologies), 5ϫ10 -5 against CD4 (FITC-conjugated GK1.5 or H129.19; PharM-M 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml streptoingen) and 7-amino actinomycin D (7-AAD; Sigma) was added mycin, 5% FCS (Sigma) and 5% concanavalin A-activated rat (at 1 µg/ml) to allow exclusion of dead cells. TCR levels were spleen supernatant.
determined using an FITC-labeled anti-C β antibody (H57-597; PharMingen). Percentages of tetramer-positive cells were Generation of peptide:I-A u tetramers expressed relative to the total number of CD4 ϩ T cells. Several modifications were made to the original construct T cell stimulation assays using recombinant peptide:I-A u used previously for the expression of recombinant I-A u molecmolecules ules (16) . The native leader sequences of α and β chains were replaced by a signal peptide sequence derived from T cell hybridomas and transfectants (10 5 /well) were stimulated at 37°C for 24 h with different concentrations of recombinant honey bee melittin (23) . A KpnI site and a sequence encoding a six residue flexible linker (GSGSGS) were engineered molecules pre-coated onto 96-well plates. IL-2 levels in the 
Results

Generation and characterization of the I-A u tetramers
The N-terminal epitope of MBP binds to the I-A u restriction element with low affinity (3,4) generating complexes with a half-life of~15 min (26) . Molecular modeling combined with site-directed mutagenesis has recently led to the conclusion that MBP1-9 does not occupy the N-terminal region of the I-A u binding cleft and the position 4 lysine interacts with the hydrophobic P6 pocket of I-A u (27) . The affinity of this peptide for I-A u can be increased~1500 times by replacing the hydrophilic lysine with tyrosine (4K → 4Y) (3,28). The available it does not affect the qualitative nature of T cell recognition. The stability of the peptide:MHC complex is critical for the generation of functional tetramers and therefore two I-A u constructs were initially generated: I-A u [4K] in which I-A u is complexed with the wild-type peptide and I-A u [4Y] comprising supernatants were determined by cytokine capture ELISA the 4Y analog bound to I-A u . Covalent linkage of the antigenic using JES6-1A12 and JES6-5H4 antibodies (PharMingen) peptide to the N-terminus of the β chain might be expected followed by Extravidin-horseradish peroxidase (Sigma). (Fig. 1A) and the level of staining was proportional to the TCR studies in H-2 u mice have indicated that these cells represent levels. Background levels of staining were observed for only a subpopulation of the entire encephalitogenic repertoire the I-A d -restricted DO11.10 hybridoma cells. Comparison of (22) . In addition, it is conceivable that the modifications tetramer staining of CD4 ϩ 1934.4 hybridoma cells and the required for the generation of MBP1-11:I-A u tetramers (4K → 1934.4 TCR transfectants P1.D2 (CD4 -) indicated that, follow-4Y substitution, replacement of the N-terminal acetyl group ing normalization for TCR expression levels, tetramer binding of MBP with glycine and anchoring the peptide to the Nis not affected by the absence of CD4 (Fig. 1B) . This is terminus of the β chain via a flexible linker) might affect consistent with the observations of others (9,29) indicating a binding to some MBP1-9-specific T cells. We addressed lack of influence of CD4 on binding of multivalent peptide:MHC these aspects by using tetramers to stain T cell lines previously complexes.
shown to encompass the MBP1-9-specific repertoire in H-2 u mice (22) . The Tg4.TCL, derived by primary in vitro stimulation Analysis of transgenic mice expressing a MBP-specific TCR of Tg4 splenocytes with MBP1-9, recognizes position 6 of The Tg4 mice (20) express a transgenic TCR (1934.4) specific MBP1-9 as the primary TCR contact and position 3 as a for MBP1-9 and utilizing V α 4.2 and V β 8.2. Of the CD4 ϩ splenic secondary contact. In contrast, the polyclonal 4Kuxs.TCL, population,~60% of cells stained with the tetramer (Fig. 2A) . In derived from wild type H-2 uϫs mice immunized with myelin contrast, analysis of splenocytes derived from non-transgenic and generated by in vitro stimulation with MBP1-9, shows a littermates failed to detect any tetramer-positive cells (Fig. 2B) reversed hierarchy of TCR contacts with position 3 as the indicating that the number of MBP1-9-specific cells in naive primary contact (22) . Tetramer staining of the Tg4.TCL mice is extremely low and providing further support for (Fig. 3A) revealed a uniform population of tetramer-positive tetramer specificity. Since the Tg4 mice are not on a Rag -/-cells whereas the 4Kuxs.TCL shows a more complex pattern nor C α knockout background, the tetramer-negative CD4 of tetramer staining with three discrete populations reflecting population in these mice most likely represents cells for which the polyclonal nature of this T cell line. A similar observation deficient allelic exclusion results in expression of endogenous was previously reported in a different system (12) and correlated with a wide range of receptor affinities. The 170.1 T cell α chains. clone specific for MBP89-101 peptide presented by I-A s population ranged from 0.14 to 0.31% for myelin and 0.28 to 0.58% for MBP1-9 primed cells. This would correspond to a stained at background levels. Analysis of the proliferative responses of the tested cell lines to plate bound recombinant population of 15,000-70,000 MBP1-9-specific T cells present in the draining lymph nodes of self-antigen immunized mice. I-A u [4Y] indicated a good correlation between responsiveness and tetramer binding (Fig. 3B) .
Consistently, the number of antigen-specific cells was 2-fold higher in mice primed with peptide than in mice Quantitation of autoreactive T cells following immunization of immunized with whole myelin. A possible reason for this is non-transgenic mice that the amount of antigen presented to the T cells is lower for SCH immunization than for MBP1-9. Although direct testing Since the very low precursor frequency of MBP1-9-specific T cells precludes their direct detection in naive animals we of this hypothesis is made difficult by obvious technical limitations, this interpretation would be consistent with the decided to analyze the expansion of these cells during a primary immune response. For this, B10.PLϫSJL/J (H-2 uϫs ) effects of peptide antigen dose on the induction/expansion of antigen-specific T cells in another system (12). Tetramermice were immunized s.c. with either MBP1-9 or whole MBP (in SCH). Both antigens were emulsified in CFA and control positive cells have also up-regulated expression of the coreceptor, CD4 (Fig. 4B ). This extends earlier observations mice received PBS in the same adjuvant. PLNC from each group were stained with anti-CD4, tetramers (or Extravidinusing other antigen systems in which CD4 up-regulation was demonstrated to be a marker for recently activated T cells PE in duplicate samples) and 7-AAD (to exclude dead cells which bind tetramer non-specifically; data not shown), and (30) . As demonstrated for the MBP1-9-specific T cell lines (Fig. 3B) , there is a good correlation between tetramer binding analyzed by flow cytometry (Fig. 4A) . In contrast to PLNC from PBS/CFA immunized mice that, similar to naive animals, and proliferative responses induced by the recombinant peptide:I-A u molecules (Fig. 4C) . show no tetramer-positive cells, in MBP1-9-and SCH-immunized mice distinct populations of tetramer-positive cells are Finally, we analyzed the expansion of antigen-specific cells following in vitro stimulation with MBP1-9. The PLNC from clearly visible. In three separate immunization experiments the percentage of tetramer-positive cells in the CD4 T cell MBP1-9 and SCH immunized animals were stimulated with MBP1-9 or, as a control, with PPD (since many of the primed response to MBP. In contrast to naive non-transgenic mice, a large population of tetramer-positive cells (~60% of CD4 cells are specific for Mycobacterium tuberculosis derived peptides) and analyzed for tetramer binding after 4 and 7 T cells) was readily detectable in mice transgenic for a MBP1-9-specific TCR (20) . days of in vitro culture. The number of tetramer-positive cells reached~10% of the CD4 cells after 4 days of in vitro MBP1-How do our observations of self-antigen-driven expansion compare with previous reports concerning the frequency of 9 stimulation and by day 7 had increased to~20% (Fig. 5) . In contrast, PPD stimulation failed to increase the number of foreign antigen-specific CD4 T cells in mice? In a previous study, McHeyzer-Williams and Davis (31) estimated the fretetramer-positive cells (data not shown). Interestingly, although fewer cells are induced by SCH immunization (Fig. quency of antigen (cytochrome c)-specific CD4 T cells to be 1 in 10 5 in naive animals and demonstrated that in the course 4A), these lymphocytes are efficiently expanded in vitro to culminate in similar, or even higher, percentages to those of the primary immune response this number increased to 50,000 in the draining lymph nodes. Our data for the primary seen for peptide-immunized mice (Fig. 5) . Possible reasons for the apparent in vitro proliferative advantage of cells immune response to MBP1-9 indicate numbers of antigenspecific T cells (15,000-70,000) in a similar range. These induced by immunization with whole protein over cells induced by peptide immunization are currently being investigated.
numbers are also close to what has been reported by others for the responses to an I-A b -restricted peptide and to hen egg lysozyme (12, 32) . Taken together with the observation Discussion that MBP1-9-specific cells are undetectable in unimmunized mice, this suggests that a large expansion of these cells In the current study we have analyzed the frequency of MBP1-9-specific T cells in naive and autoantigen-immunized occurs during the primary response. In this context, studies in mice transgenic for different MBP1-9-specific TCRs mice. For this we have generated MHC class II tetramers comprising I-A u complexed with the immunodominant epitope (20, 33, 34) indicate that MBP1-9-specific T cells escape central tolerance induction despite thymic expression of MBP (35) of MBP. The ability of these multimeric reagents to capture a diverse repertoire of MBP1-9-specific T cells has been due to the low affinity of this epitope for I-A u . More recent studies in non-transgenic mice (7) have shown that thymic characterized using representative T cell lines. Although the very low precursor frequencies of MBP1-9-specific T cells expression of MBP does not have a negative influence on the MBP1-9-specific T cell repertoire. Therefore, the lack of precluded their detection in naive mice, we could reliably detect the expansion of these cells during the primary immune negative selection would be predicted to result in precursor where the mechanism for escape from tolerance has not as yet been elucidated. Such quantitative studies could also be used to test models in which partial tolerance is believed to References result from deletion of high-avidity T cells whilst allowing low- An unexpected observation of the current study is that the In summary, the current study describes a quantitative 
